2 Life Sciences Cos. Set Terms Amid Quiet Period For IPOs
By Chelsea Naso ( March 10, 2015, 1:54 PM EDT) -- Two venture capital-backed life sciences companies — a commercial-stage diabetes treatment maker and an orphan disease treatment developer — fine-tuned their initial public offering plans Monday as a so-far relatively quiet year in IPO activity prepares to pick up speed....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.